Elicio Therapeutics, Inc.ELTXNASDAQ
Loading
Gross Profit Growth Recovery in ProgressRecovering
Percentile Rank78
5Y CAGR-53.8%
Studio
Year-over-Year Change

Year-over-year gross profit growth rate

5Y CAGR
-53.8%/yr
Long-term compound
Percentile
P78
Within normal range
vs 5Y Ago
0x
Contraction
Streak
3 yr
Consecutive growthRecovering
PeriodValue
20254.24%
2024-0.68%
2023-10.69%
2022-103.90%
20212449.72%
2020202.56%
2019-90.38%
20180.00%
2013-5.97%
20120.00%